Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

4.27
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.88
Today|||52-Week Range
9.40
-18.98%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close4.27
Today’s open4.10
Day’s range4.05 - 4.30
Volume400,160
Average volume (3 months)279,413
Market cap$128.1M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-0.77%
Earnings growth (this year)+50.38%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.38
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...0.000.00%
VRNAVerona Pharma PLC0.000.00%
SMMTSummit Therapeutics ...0.000.00%
NTECIntec Pharma Ltd0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$799.0K
Annual profit (last year)-$29.7M
Net profit margin-3,721.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Executive VP, Chief Operating &
Financial Officer
Keith W. Marshall
Corporate headquarters
San Diego, California

Forecasts